Joseph Clyde, MD
Radiation Oncology · Great Falls, MTNPI 1710478698
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $810 of the $1,165 with a category attached, or 69.5%. Teleflex LLC accounts for 81.3% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $1,060, more than ten times the $77 reported in 2023.
Across 10 payments — averaging $116.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$947
- Boston Scientific$59
- Progenics Pharmaceuticals, Inc.$57
- Siemens Medical Solutions USA, Inc.$29
- Pfizer$19
- Novartis$19
- plus $36 from 2 others
What the payments were for
- Travel & lodging$81070%
- Food & beverage$35530%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 3 | $947 |
| Boston Scientific | 1 | $59 |
| Progenics Pharmaceuticals, Inc. | 1 | $57 |
| Siemens Medical Solutions USA, Inc. | 1 | $29 |
| Pfizer | 1 | $19 |
| Novartis | 1 | $19 |
| AbbVie | 1 | $18 |
| Novocure Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few radiation oncology providers in Montanato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 13 | $33,791 |
| Tamsulosin Hcl | 27 | $258 |
| Bicalutamide | 16 | $190 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Great Falls
- Berna DemalignonGreat Falls$5K
- Carolyn RutterGreat Falls$2K
- Christopher BakerBozeman$2K
- Jeffrey EshlemanKalispell$1K
- Justin LinamKalispell$687
- Ralf KiehlSidney$538
- Trent MihalickBillings$352
- John SchallenkampBillings$274
- Michelle ProperMissoula$245
- Gordon StillieKalispell$231
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.